Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Not Confirmed
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
15-16 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
DIA Global Annual Meet...DIA Global Annual Meeting
Industry Trade Show
Not Confirmed
14-18 June, 2026
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
15-16 June, 2026
Digital content

11 Jun 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/dksh-enters-strategic-distribution-partnership-with-bridgebio-to-support-regulatory-evaluation-and-potential-patient-access-to-transthyretin-stabilizer-for-attr-cm-in-selected-asia-pacific-markets-302797704.html

27 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/27/3301817/0/en/bridgebio-announces-fda-acceptance-and-priority-review-of-nda-for-bbp-418-for-lgmd2i-r9.html

12 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/12/3292712/0/en/bridgebio-submits-nda-to-fda-for-encaleret-for-individuals-living-with-adh1.html

12 May 2026
// BIOSPACE
https://www.biospace.com/drug-development/bridgebio-stands-up-to-pfizer-in-attr-cm-as-late-stage-data-hint-at-better-survival

11 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/11/3291995/0/en/acoramidis-continues-to-demonstrate-disease-modifying-effects-in-attr-cm-reducing-sttr-variability-and-outpatient-worsening-heart-failure.html

08 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/08/3291319/0/en/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE